Morbidity  	Morbidity  	 NNP	O
and  	and  	 CC	O
mortality  	mortality  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
haemophilia  	haemophilia  	 NN	O
in  	in  	 IN	O
Germany  	Germany  	 NNP	O
2007 	2007 	 CD	O
/ 	/ 	 CD	O
2008  	2008  	 CD	O
Since  	Since  	 IN	O
1978  	1978  	 CD	O
an  	an  	 DT	O
annual  	annual  	 JJ	O
multicentric  	multicentric  	 JJ	B-NP
survey  	survey  	 NN	I-NP
regarding  	regarding  	 VBG	O
the  	the  	 DT	O
epidemiology  	epidemiology  	 NN	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
suffering  	suffering  	 VBG	O
of  	of  	 IN	O
haemophilia  	haemophilia  	 NN	O
is  	is  	 VBZ	O
performed  	performed  	 VBN	O
with  	with  	 IN	O
support  	support  	 NN	O
of  	of  	 IN	O
haemophilia  	haemophilia  	 NNS	O
treating  	treating  	 VBG	B-NP
centres  	centres  	 NN	I-NP
of  	of  	 IN	O
any  	any  	 DT	O
size 	size 	 NN	O
.  	.  	 .	O
Again  	Again  	 RB	O
the  	the  	 DT	O
actual  	actual  	 JJ	O
compilation  	compilation  	 NN	O
is  	is  	 VBZ	O
resting  	resting  	 VBN	O
upon  	upon  	 IN	O
a  	a  	 DT	O
broad  	broad  	 JJ	O
database  	database  	 NN	O
returning  	returning  	 VBG	O
to  	to  	 TO	O
over  	over  	 IN	O
30  	30  	 CD	O
years  	years  	 NNS	O
of  	of  	 IN	O
inquiry  	inquiry  	 NN	B-NP
well  	well  	 RB	O
representing  	representing  	 VBG	O
both  	both  	 PDT	O
the  	the  	 DT	O
actual  	actual  	 JJ	O
and  	and  	 CC	O
retrospective  	retrospective  	 JJ	B-NP
status  	status  	 NN	I-NP
of  	of  	 IN	O
mortality 	mortality 	 NN	O
.  	.  	 .	O
Prompted  	Prompted  	 NNP	O
was  	was  	 VBD	O
exclusively  	exclusively  	 RB	O
information  	information  	 NN	O
about  	about  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
haemophilia  	haemophilia  	 JJ	O
A 	A 	 NN	O
,  	,  	 ,	O
B  	B  	 NNP	O
and  	and  	 CC	O
von  	von  	 NNP	B-NP
Willebrand  	Willebrand  	 NNP	I-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
In  	In  	 IN	O
particular  	particular  	 JJ	O
anonymous  	anonymous  	 JJ	O
data  	data  	 NNS	O
concerning  	concerning  	 VBG	O
the  	the  	 DT	O
last  	last  	 JJ	O
12  	12  	 CD	O
months  	months  	 NNS	O
about  	about  	 IN	O
number  	number  	 NN	O
of  	of  	 IN	O
treated  	treated  	 JJ	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
type  	type  	 NN	O
and  	and  	 CC	O
severity  	severity  	 NN	O
of  	of  	 IN	O
illness 	illness 	 NN	O
,  	,  	 ,	O
HIV-status  	HIV-status  	 JJ	B-NP
and  	and  	 CC	O
detailed  	detailed  	 JJ	O
information  	information  	 NN	O
about  	about  	 IN	O
causes  	causes  	 NNS	O
of  	of  	 IN	O
death  	death  	 NN	O
was  	was  	 VBD	O
inquired 	inquired 	 VBN	O
.  	.  	 .	O
This  	This  	 DT	O
data  	data  	 NNS	O
was  	was  	 VBD	O
merged  	merged  	 VBN	O
with  	with  	 IN	O
existing  	existing  	 VBG	O
data  	data  	 NNS	O
and  	and  	 CC	O
analyzed  	analyzed  	 VBD	O
statistically 	statistically 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
2007 	2007 	 CD	O
/ 	/ 	 CD	O
2008  	2008  	 CD	O
survey 	survey 	 NN	O
,  	,  	 ,	O
a  	a  	 DT	O
total  	total  	 JJ	O
number  	number  	 NN	O
of  	of  	 IN	O
8904  	8904  	 CD	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
bleeding  	bleeding  	 VBG	B-NP
disorders  	disorders  	 NNS	I-NP
have  	have  	 VBP	O
been  	been  	 VBN	O
reported  	reported  	 VBN	O
from  	from  	 IN	O
63  	63  	 CD	O
participating  	participating  	 VBG	B-NP
centres 	centres 	 NNS	I-NP
.  	.  	 .	O
Despite  	Despite  	 IN	O
mortality  	mortality  	 NN	O
from  	from  	 IN	O
HIV  	HIV  	 NNP	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
haemophilia  	haemophilia  	 NN	O
is  	is  	 VBZ	O
keeping  	keeping  	 VBG	O
on  	on  	 IN	O
decreasing 	decreasing 	 VBG	O
,  	,  	 ,	O
HIV  	HIV  	 NNP	B-NP
still  	still  	 RB	O
remains  	remains  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
factor  	factor  	 NN	B-NP
as  	as  	 IN	O
an  	an  	 DT	O
HIV 	HIV 	 NNP	B-NP
/ 	/ 	 NNP	I-NP
HCV  	HCV  	 NNP	I-NP
coinfection  	coinfection  	 NN	I-NP
seems  	seems  	 VBZ	O
to  	to  	 TO	O
increase  	increase  	 VB	O
risk  	risk  	 NN	O
of  	of  	 IN	O
progression  	progression  	 NN	O
of  	of  	 IN	O
severe  	severe  	 JJ	O
liver  	liver  	 NN	O
disease 	disease 	 NN	O
.  	.  	 .	O
Age  	Age  	 NN	B-NP
structure  	structure  	 NN	I-NP
in  	in  	 IN	O
our  	our  	 PRP$	O
patients  	patients  	 NNS	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
shifting  	shifting  	 VBG	O
significantly  	significantly  	 RB	O
over  	over  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
decades  	decades  	 NNS	O
bringing  	bringing  	 VBG	B-NP
age  	age  	 NN	I-NP
distribution  	distribution  	 NN	I-NP
into  	into  	 IN	O
line  	line  	 NN	O
with  	with  	 IN	O
the  	the  	 DT	O
entire  	entire  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
This  	This  	 DT	O
has  	has  	 VBZ	O
to  	to  	 TO	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
assessing  	assessing  	 VBG	B-NP
mortality  	mortality  	 NN	I-NP
and  	and  	 CC	O
morbidity 	morbidity 	 NN	O
.  	.  	 .	O
